A comparison of eight methods for the dual-endpoint evaluation of efficacy in a proof-of-concept HIV vaccine trial.
about
Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trialSensitivity analyses comparing time-to-event outcomes only existing in a subset selected postrandomization and relaxing monotonicityStatistical methods for the analysis of clinical trials data containing many zeros: An application in vaccine development.Semiparametric estimation of the average causal effect of treatment on an outcome measured after a postrandomization event, with missing outcome data.Null but not void: considerations for hypothesis testing.Some design issues in phase 2B vs phase 3 prevention trials for testing efficacy of products or conceptsMatching for Several Sparse Nominal Variables in a Case-Control Study of Readmission Following Surgery.Statistical interpretation of the RV144 HIV vaccine efficacy trial in Thailand: a case study for statistical issues in efficacy trials.AIDS vaccines and preexposure prophylaxis: is synergy possible?Randomization-Based Inference within Principal Strata.Incorporating founder virus information in vaccine field trials.ASSESSING SURROGATE ENDPOINTS IN VACCINE TRIALS WITH CASE-COHORT SAMPLING AND THE COX MODEL.Lower Viral Loads and Slower CD4+ T-Cell Count Decline in MRKAd5 HIV-1 Vaccinees Expressing Disease-Susceptible HLA-B*58:02Evaluating a surrogate endpoint at three levels, with application to vaccine development.Post-step modifications for research on HIV vaccinesNew clinical trial designs for HIV vaccine evaluation.Rank-based principal stratum sensitivity analyses.Chop-lump tests for vaccine trials.Flagging clinical adverse experiences: reducing false discoveries without materially compromising power for detecting true signals.
P2860
Q28972526-F47D2A45-D089-474F-AB80-5B175DEF2B72Q30501153-DD64B732-E253-4CBC-9E36-57AF943250DEQ30824920-F0AA6D4F-9F29-4075-9982-1EDE5E1460A8Q33509461-F07D69C1-D873-49B6-8624-8AFC27068536Q33666431-C51B6EB4-3664-451A-9F3F-28B526048A26Q34090592-9E12F683-3A90-4FF6-803D-3F969A2BD4AAQ34540510-7FCCF5A6-EAD1-4706-85B8-AA818174F318Q34743329-4E3440E5-E1EE-4400-8B59-5A7DB3E8CE36Q35003539-7C6C3732-F6B5-4EB7-ADB2-F60CA8920E3DQ35285899-E4C98A3F-032B-4A48-B095-2434D573F234Q36509005-1854B63A-9F93-4733-92C0-E0D06C08C5D1Q37012786-C55511AA-8AD2-401B-A1A0-16DA1D85A8B5Q37074610-C718A609-09ED-40A7-A017-A2048727501DQ37107029-A2A831A9-A8A8-4126-8FD6-E7E273CB33E8Q37287027-4B71B699-6DB3-402D-994D-A2D5134DE705Q37412300-DD6BF8FB-92B5-4A6D-A211-167420C1BE56Q45844211-231A79B4-78CB-4229-941C-51D7257FFCADQ47894801-8DA843BC-64A6-410F-923E-47DDC2C2CBECQ48023863-AC1D38A2-30FF-4BED-AB8C-C52E520E62F7
P2860
A comparison of eight methods for the dual-endpoint evaluation of efficacy in a proof-of-concept HIV vaccine trial.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh-hant
name
A comparison of eight methods ...... -of-concept HIV vaccine trial.
@en
A comparison of eight methods ...... -of-concept HIV vaccine trial.
@nl
type
label
A comparison of eight methods ...... -of-concept HIV vaccine trial.
@en
A comparison of eight methods ...... -of-concept HIV vaccine trial.
@nl
prefLabel
A comparison of eight methods ...... -of-concept HIV vaccine trial.
@en
A comparison of eight methods ...... -of-concept HIV vaccine trial.
@nl
P2093
P2860
P1433
P1476
A comparison of eight methods ...... -of-concept HIV vaccine trial.
@en
P2093
Devan V Mehrotra
Peter B Gilbert
Xiaoming Li
P2860
P304
P356
10.1111/J.1541-0420.2005.00516.X
P407
P577
2006-09-01T00:00:00Z